HIGHFDA DRUG

Asteria Health Recalling Estradiol Pellets Due to Metal Contamination

Asteria Health recalled 22,478 Estradiol 12.5 mg pellets on January 26, 2026, due to potential metal particulate contamination. Consumers and healthcare providers must stop using the product immediately. The FDA classified this recall as Class II, indicating a high hazard level.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
January 26, 2026
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
January 26, 2026
Hazard Level
HIGH
Brand
F.H. INVESTMENTS, Inc.
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
F.H. INVESTMENTS, Inc.
Product type
Hormonal Pellet
Model numbers
Lot#: 253000117, Exp. 02/21/2026, 253000129, Exp. 06/12/2026, 253000130, Exp. 06/16/2026, 253000154, 253000155 +3 more
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    January 26, 2026

  2. Reported by FDA DRUG

    February 18, 2026

  3. RecallRadar source check

    February 25, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Presence of Foreign substance - potential presence of metal particulate matter

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact F.H. INVESTMENTS, Inc. (dba Asteria Health) or your healthcare provider for guidance. Notification method: Letter

About This Product

Estradiol pellets are used in hormone replacement therapy to treat symptoms of menopause and other hormonal imbalances. They provide a steady release of hormones into the body over time, making them a preferred option for many patients.

Why This Is Dangerous

The potential presence of metal particulate matter in the pellets can occur during manufacturing or packaging processes. Ingestion of these particles could lead to serious health risks, including injury or adverse effects.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

Consumers should take immediate action to stop using the product, as the contamination poses significant health risks. This recall may cause inconvenience and concern for those relying on these pellets for hormone therapy.

Practical Guidance

How to identify if yours is affected

  1. Check the product packaging for the lot number.
  2. Identify if your lot number matches any of the recalled numbers: 253000117, 253000129, 253000130, 253000154, 253000155, 253000160.
  3. Consult your healthcare provider for further guidance.

Where to find product info

Lot numbers are usually printed on the packaging or label of the product. Expiration dates are also printed on the same area.

What timeline to expect

Expect a refund processing timeline of 4-6 weeks after returning the recalled product.

If the manufacturer is unresponsive

  • Contact Asteria Health directly via their customer service line.
  • Keep a record of all communications regarding the recall.

How to prevent similar issues

  • Always check for recalls before using new medications.
  • Consult with healthcare providers about the safety of products before use.
  • Look for FDA approval and recall history in the future.

Documentation advice

Keep all receipts and correspondence regarding the recall for your records.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

The recalled product is Estradiol, 12.5 mg, sold in sterile pellet form. The affected lot numbers include 253000117, 253000129, 253000130, 253000154, 253000155, and 253000160 with various expiration dates up to September 10, 2026. The product was distributed nationwide in the USA.

Key Facts

  • Recall classification: Class II
  • Hazard: Potential metal contamination
  • Stop use immediately and contact healthcare provider

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product Details

Model Numbers
Lot#: 253000117
Exp. 02/21/2026
253000129
Exp. 06/12/2026
253000130
+6 more
Affected States
ALL
Report Date
February 18, 2026
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
HIGH

Asteria Health Recalls Estradiol Pellets Over Metal Contamination

Asteria Health recalled 24,099 Estradiol, 10 mg pellets on January 26, 2026, due to potential metal particulate contamination. Consumers should stop using the product immediately. The recall affects pellets distributed nationwide in the USA.

F.H. INVESTMENTS, Inc.
Presence of
Read more